Table 3 Enriched and potentially deleterious variants in samples from England

From: Regionally enriched rare deleterious exonic variants in the UK and Ireland

ClinVar Variant Allele ID

Gene

Condition

Region

MAFREG

Enrichment (vs MAFNFE)

MAFAVE

HOMALT range

226048

PEX6

Zellweger syndrome

Lancs

0.0022

73x

0.00030

[1,7]

32480

COL7A1

Dystrophic epidermolysis bullosa

Notts

Lancs

0.0010

0.0008

65x

57x

0.00028

[0,1]

[0,1]

186978

G6PC

Glycogen storage disease

Yorks

0.0009

62x

0.00011

[1,4]

185684

CLPB

3-Methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia

Notts

0.0008

57x

0.00018

[0,1]

359454

COL7A1

Dystrophic epidermolysis bullosa

Yorks

0.0008

52x

0.00023

[1,3]

431680

PDE6A

Retinitis pigmentosa

Staffs

0.0007

48x

0.00016

[0,0]

19010

ALMS1

Alstrom syndrome

Lancs

Staffs

Notts

0.0020

0.0017

0.0012

27x

23x

16x

0.00064

[2,6]

[2,3]

[1,1]

611902

PEPD

Prolidase deficiency

Notts

0.0010

22x

0.00017

[0,1]

249211

FIG4

Amyotrophic lateral sclerosis

Notts

0.0006

20x

0.00018

[0,0]

190033

DRAM2

Retinal Dystrophy

Lancs

0.0012

20x

0.00031

[1,2]

100244

DYSF

Limb-girdle muscular dystrophy

Staffs

0.0010

14x

0.00026

[0,1]

100251

DYSF

Limb-girdle muscular dystrophy

Staffs

0.0010

14x

0.00015

[0,1]

26935

F11

Hereditary factor XI deficiency disease

Lancs

Yorks

0.0013

0.0011

13x

10x

0.00039

[1,3]

[2,7]

33396

CHRNE

Myasthenic syndrome

Lancs

0.0017

13x

0.00045

[1,4]

240612

DNAI1

Primary ciliary dyskinesia

Staffs

0.0011

11x

0.00021

[0,1]

29030

PNP

Purine-nucleoside phosphorylase deficiency

England NE

0.0012

10x

0.00026

[1,4]

443176

COL4A4

Alport syndrome

Staffs

Lancs

0.0014

0.0013

9.6x

9.0x

0.00048

[1,2]

[1,3]

203474

PNPO

Pyridoxal phosphate-responsive seizures

Staffs

0.0017

9.6x

0.00038

[1,3]

16237

MARVELD2

Deafness, autosomal recessive 49

Lancs

0.0015

8.5x

0.00043

[1,3]

272434

SLC7A9

Cystinuria

Lancs

0.0022

8.2x

0.00077

[3,7]

489962

TECTA

Nonsyndromic hearing loss and deafness

Notts

0.0012

5.8x

0.00034

[0,1]

76544

DNAH5

Primary Ciliary Dyskinesia

Lancs

0.0020

5.2x

0.00064

[2,6]

  1. MAFREG: regional MAF of the variant.
  2. MAFNFE: MAF of the variant in Non-Finnish European individuals in gnomAD.
  3. MAFAVE: average MAF of the variant in the dataset of 10,001 unrelated individuals from 20 UK and Ireland regions.
  4. HOMALT range: predicted range of the regional number of individuals homozygous for the variant.